Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4899 USD | +0.60% | -12.22% | -86.50% |
08/04 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
21/03 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- KA Stock
- Revisions Kineta, Inc.